These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11563596)

  • 41. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
    Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
    Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma.
    Liao CA; Lee CM; Wu HC; Wang MC; Lu SN; Eng HL
    Br J Haematol; 2002 Jan; 116(1):166-9. PubMed ID: 11841412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Lamivudine for the prevention of chronic hepatitis B exacerbations during chemotherapy for non-Hodgkin's lymphoma].
    van der Eijk AA; Doorduijn JK; Janssen HL; Schalm SW; Niesters HG; de Man RA
    Ned Tijdschr Geneeskd; 2002 Jun; 146(24):1140-4. PubMed ID: 12092307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.
    Loglio A; Viganò M; Grossi G; Labanca S; Goldaniga M; Pompa A; Farina L; Rumi M; Corradini P; Facchetti F; Lunghi G; Baldini L; Lampertico P
    Dig Liver Dis; 2019 Mar; 51(3):419-424. PubMed ID: 30316785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.
    Hsu C; Tsou HH; Lin SJ; Wang MC; Yao M; Hwang WL; Kao WY; Chiu CF; Lin SF; Lin J; Chang CS; Tien HF; Liu TW; Chen PJ; Cheng AL;
    Hepatology; 2014 Jun; 59(6):2092-100. PubMed ID: 24002804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature.
    Roussos A; Koilakou S; Kalafatas I; Kalantzis C; Apostolou N; Grivas E; Raptis N; Mantzaris G
    Acta Gastroenterol Belg; 2008; 71(1):30-2. PubMed ID: 18396747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
    Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
    Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies.
    Pelizzari AM; Motta M; Cariani E; Turconi P; Borlenghi E; Rossi G
    Hematol J; 2004; 5(4):325-8. PubMed ID: 15297849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute liver failure related to chemotherapy.
    Wijaya I; Sanityoso A; Lesmana LA
    Acta Med Indones; 2012 Apr; 44(2):145-9. PubMed ID: 22745146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.
    ter Borg F; Smorenburg S; de Man RA; Rietbroek RC; Chamuleau RA; Jones EA
    Dig Dis Sci; 1998 Oct; 43(10):2267-70. PubMed ID: 9790464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
    He YF; Li YH; Wang FH; Jiang WQ; Xu RH; Sun XF; Xia ZJ; Huang HQ; Lin TY; Zhang L; Bao SP; He YJ; Guan ZZ
    Ann Hematol; 2008 Jun; 87(6):481-5. PubMed ID: 18299831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lamivudine prophylaxis for chemotherapy induced reactivation hepatitis B: a case report and review.
    Mills SJ; Berenberg JL; Ramos F
    Hawaii Med J; 2003 Oct; 62(10):220-2. PubMed ID: 14631594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
    Moses SE; Lim ZY; Sudhanva M; Devereux S; Ho AY; Pagliuca A; Zuckerman M; Mufti GJ
    J Med Virol; 2006 Dec; 78(12):1560-3. PubMed ID: 17063522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.
    Zell JA; Yoon EJ; Ignatius Ou SH; Hoefs JC; Chang JC
    Anticancer Drugs; 2005 Jan; 16(1):83-5. PubMed ID: 15613909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience.
    Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H
    Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
    Law JK; Ho JK; Hoskins PJ; Erb SR; Steinbrecher UP; Yoshida EM
    Leuk Lymphoma; 2005 Jul; 46(7):1085-9. PubMed ID: 16019563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fulminant hepatitis B and acute hepatitis B due to intrafamilial transmission of HBV after chemotherapy for non-Hodgkin's lymphoma in an HBV carrier.
    Aomatsu T; Komatsu H; Yoden A; Hosomi A; Miyazaki H; Sogo T; Inui A; Fujisawa T; Tamai H
    Eur J Pediatr; 2010 Feb; 169(2):167-71. PubMed ID: 19466454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
    Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
    Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
    Viganò M; Mangia G; Lampertico P
    Expert Opin Biol Ther; 2014 Jul; 14(7):1019-31. PubMed ID: 24909454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery.
    Lau CF; Hui PK; Chan WM; Fung TT; Tung YM; Loo CK; Yip WC; Lam KM
    Eur J Gastroenterol Hepatol; 2002 May; 14(5):563-6. PubMed ID: 11984157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.